BifidoLab

BIFIDO is a South Korean biotechnology company specializing in the research, development, and manufacturing of human-origin probiotics, particularly Bifidobacterium strains. Founded by Dr. Geun Eog Ji, the company utilizes its proprietary BIFIDO-Express platform to develop live biotherapeutic products (LBPs) and functional foods. Their business spans from raw material production to finished consumer goods under brands like BifidoLab, which focuses on probiotic-based skincare, and ZIGUNUK, a supplement line. BIFIDO is actively pursuing clinical-stage drug development for indications such as rheumatoid arthritis and atopic dermatitis using specific microbial strains. The company is listed on the KOSDAQ and operates a GMP-certified manufacturing facility to support its global distribution and CDMO services.